JUL 29, 2020 9:00 AM PDT

Implementation of Dried Blood Spots (DBS) for Hepatitis C (HCV) Elimination

Speakers
  • Biography

      Elisa did her Master’s in Clinical Microbiology at the Microbiology Department in Germans Trias i Pujol University Hospital, within Germans Trias i Pujol Research Institute (IGTP), Barcelona, Spain. Then, she was guest researcher at the Centers for Disease Control and Prevention (CDC) in Atlanta, USA, where she undertook the experimental part of her PhD from 2001 to 2003. Afterwards, she completed her predoctoral training at the Center of Epidemiological Studies on HIV/STIs in Catalonia (CEEISCAT), and defended her doctoral thesis in 2005, for which she received two awards. Back at the Microbiology Department in Germans Trias i Pujol Hospital, Dr. Martró started a research line on hepatitis C virus in 2006 as a postdoc, and then as a principal investigator since 2010, when she entered the Miguel Servet programme funded by the Spanish Government. Since then, Dr. Martró leads the research group on Clinical Virology and New Diagnostic Approaches at IGTP. The research focus of her group was originally the study of HCV genetic variability and its clinical applications in personalized medicine, and the characterization of HCV molecular epidemiology. Dr. Martro’s current research is focussed on improving HCV diagnosis in vulnerable groups (MSM, sex workers, PWIDs and migrants) in the community setting through novel molecular assays and screening strategies. Her work characterising the local HCV epidemics in these collectives has led her to participate in the Commission for the elaboration of the “Plan for the Prevention and Control of hepatitis C in Catalonia”. She is also a member of Group 27 of CIBER in Epidemiology and Public Health (CIBERESP) of Instituto de Salud Carlos III and of the Clinical Microbiology.



       

    • Biography

        Emmanuel received his BSc Honors degree in Microbiology in 2004 from the University of Antioquia, Medellin, Colombia and his MSc degree in Epidemiology in 2017 from the London School of Hygiene & Tropical Medicine, London, UK. He has worked for over 15 years as diagnostics advisor in variety of resource-limited settings in sub-Saharan Africa, Central Asia and the Western Pacific strengthening laboratory capacity for the diagnosis and response of infectious diseases including HIV, TB, Viral Hepatitis and STIs. He currently works with FIND in the HCV R&D Program.  

      • Biography

          Dr. Meehan serves as Hepatitis Diagnostics Program Manager at the Clinton Health Access Initiative (CHAI). Tim has a PhD in Diagnostics and a commercial background developing molecular and point of care tests for infectious diseases in low resource settings. He is an experienced team leader with extensive experience working internationally in cross-disciplinary environments.


        Abstract

        DATE:  July 29, 2020

        TIME:   9:00am PDT, 12:009m EDT, 6:00pm CEST

         

        Hepatitis C infection, once a formidable enemy, is now a curable disease. Dramatic advances in antiviral therapies have launched a new era in how hepatitis C is treated and in turn have significantly improved the prognosis once an infection is identified. Unfortunately, many individuals today who are infected with hepatitis C are completely unaware of infection status; it is estimated that only 20% of cases worldwide are diagnosed.  Only when individuals are tested and diagnosed with a hepatitis C virus (HCV) infection can they be treated and reap the benefits of these therapeutic innovations. Bridging the gap between unaware and diagnosed can make huge differences in a patient’s long-term prognosis. 

         

        Learning Objectives:

        • Underatand HCV disease state overview
        • Discuss the Role of Dried Blood Spots (DBS) in management of HCV infection
        • Discuss the Performance of m2000 RealTime HCV DBS
        • Discuss Implementation strategies for HCV elimination

         

        Webinars will be available for unlimited on-demand viewing after live event.
         
        LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


        Show Resources
        You May Also Like
        APR 07, 2020 8:00 AM PDT
        C.E. CREDITS
        APR 07, 2020 8:00 AM PDT
        DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
        JUN 09, 2020 10:00 AM PDT
        C.E. CREDITS
        JUN 09, 2020 10:00 AM PDT
        DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
        FEB 26, 2020 9:00 AM PST
        C.E. CREDITS
        FEB 26, 2020 9:00 AM PST
        DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
        AUG 18, 2020 10:00 AM PDT
        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
        C.E. CREDITS
        AUG 18, 2020 10:00 AM PDT
        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
        DATE: August 18, 2020 TIME: 10:00am PT Get deeper understanding of gene expression patterns by using assays that retain spatial organization at single cell resolution! Come learn about the n...
        MAY 08, 2020 10:00 AM PDT
        C.E. CREDITS
        MAY 08, 2020 10:00 AM PDT
        DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
        JUN 23, 2020 10:00 AM PDT
        C.E. CREDITS
        JUN 23, 2020 10:00 AM PDT
        DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
        Loading Comments...
        Show Resources
        Attendees
        • See more